A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

• Status: Withdrawn
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate IOP response to experimental dose of Latanoprost- PPDS in subjects with ocular hypertension or open-angle glaucoma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mati Therapeutics Inc.
• Treatments: Latanoprost

Criteria

Inclusion Criteria:

• Over 18 yrs of age with ocular hypertension or open-angle glaucoma

• Subjects who have a best corrected visual acuity of 20/100 or better

Exclusion Criteria:

• Subjects who wear contact lenses.

• Uncontrolled medical conditions

• Subjects requiring chronic topical artifical tears, lubricants and/or requiring any other chronic topical medications

• Subjects who have a history of chronic or recurrent inflammatory eye disease